Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Genetic mutations, such as activation of the KRAS2 oncogene, inactivation of the tumor-suppressor gene CDKN2A, inactivation of the tumor-suppressor gene TP53 and deleted in pancreatic cancer 4 (DPC4) gene defects are seen in those with pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP270215.RA-w-n_YRnJRSZCHNS_m2LqVuPnizX-ziNKVZivZ3jTDo130_assertion description "[Genetic mutations, such as activation of the KRAS2 oncogene, inactivation of the tumor-suppressor gene CDKN2A, inactivation of the tumor-suppressor gene TP53 and deleted in pancreatic cancer 4 (DPC4) gene defects are seen in those with pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP270215.RA-w-n_YRnJRSZCHNS_m2LqVuPnizX-ziNKVZivZ3jTDo130_provenance.
• NP544080.RAToeMfq90dsmHcIKpYcoCjFV37E84le3EmROoRtACxKU130_assertion description "[Genetic mutations, such as activation of the KRAS2 oncogene, inactivation of the tumor-suppressor gene CDKN2A, inactivation of the tumor-suppressor gene TP53 and deleted in pancreatic cancer 4 (DPC4) gene defects are seen in those with pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP544080.RAToeMfq90dsmHcIKpYcoCjFV37E84le3EmROoRtACxKU130_provenance.
• NP544156.RAWWHTftBLFX8MNgZ6NuxguLrgejiROprXvfFPyKcdCIM130_assertion description "[Genetic mutations, such as activation of the KRAS2 oncogene, inactivation of the tumor-suppressor gene CDKN2A, inactivation of the tumor-suppressor gene TP53 and deleted in pancreatic cancer 4 (DPC4) gene defects are seen in those with pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP544156.RAWWHTftBLFX8MNgZ6NuxguLrgejiROprXvfFPyKcdCIM130_provenance.
• assertion description "[Genetic mutations, such as activation of the KRAS2 oncogene, inactivation of the tumor-suppressor gene CDKN2A, inactivation of the tumor-suppressor gene TP53 and deleted in pancreatic cancer 4 (DPC4) gene defects are seen in those with pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Genetic mutations, such as activation of the KRAS2 oncogene, inactivation of the tumor-suppressor gene CDKN2A, inactivation of the tumor-suppressor gene TP53 and deleted in pancreatic cancer 4 (DPC4) gene defects are seen in those with pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Genetic mutations, such as activation of the KRAS2 oncogene, inactivation of the tumor-suppressor gene CDKN2A, inactivation of the tumor-suppressor gene TP53 and deleted in pancreatic cancer 4 (DPC4) gene defects are seen in those with pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Genetic mutations, such as activation of the KRAS2 oncogene, inactivation of the tumor-suppressor gene CDKN2A, inactivation of the tumor-suppressor gene TP53 and deleted in pancreatic cancer 4 (DPC4) gene defects are seen in those with pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1051493.RAU5bJ1yQBCIWaUcE7F_limFPxE9SmUkGu5oyL7W--eW8130_assertion description "[Genetic mutations, such as activation of the KRAS2 oncogene, inactivation of the tumor-suppressor gene CDKN2A, inactivation of the tumor-suppressor gene TP53 and deleted in pancreatic cancer 4 (DPC4) gene defects are seen in those with pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1051493.RAU5bJ1yQBCIWaUcE7F_limFPxE9SmUkGu5oyL7W--eW8130_provenance.
• NP1051494.RAX4ylIIGlkPNi9TY9QVQ3SFX0fA2K5gyy8HmZoHhRV1A130_assertion description "[Genetic mutations, such as activation of the KRAS2 oncogene, inactivation of the tumor-suppressor gene CDKN2A, inactivation of the tumor-suppressor gene TP53 and deleted in pancreatic cancer 4 (DPC4) gene defects are seen in those with pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1051494.RAX4ylIIGlkPNi9TY9QVQ3SFX0fA2K5gyy8HmZoHhRV1A130_provenance.
• NP1051495.RAmczXoEDU_e0kRP4p1qG6yhL_4xG9cT-OEF4NJx18PPM130_assertion description "[Genetic mutations, such as activation of the KRAS2 oncogene, inactivation of the tumor-suppressor gene CDKN2A, inactivation of the tumor-suppressor gene TP53 and deleted in pancreatic cancer 4 (DPC4) gene defects are seen in those with pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1051495.RAmczXoEDU_e0kRP4p1qG6yhL_4xG9cT-OEF4NJx18PPM130_provenance.
• NP1051497.RAjsmiylCB38aoJTLFKm5AZxEWDMSZCT5pWfksEQUCEG0130_assertion description "[Genetic mutations, such as activation of the KRAS2 oncogene, inactivation of the tumor-suppressor gene CDKN2A, inactivation of the tumor-suppressor gene TP53 and deleted in pancreatic cancer 4 (DPC4) gene defects are seen in those with pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1051497.RAjsmiylCB38aoJTLFKm5AZxEWDMSZCT5pWfksEQUCEG0130_provenance.
• NP1051499.RAnzke6HKAB3YU5Tc0uwAboAyFda78djNaYTAzdlYiZgo130_assertion description "[Genetic mutations, such as activation of the KRAS2 oncogene, inactivation of the tumor-suppressor gene CDKN2A, inactivation of the tumor-suppressor gene TP53 and deleted in pancreatic cancer 4 (DPC4) gene defects are seen in those with pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1051499.RAnzke6HKAB3YU5Tc0uwAboAyFda78djNaYTAzdlYiZgo130_provenance.
• NP1051496.RAKeFAqTs77gQmfqlnfrhaT20xuKon-YH4oWA3unNw_Z0130_assertion description "[Genetic mutations, such as activation of the KRAS2 oncogene, inactivation of the tumor-suppressor gene CDKN2A, inactivation of the tumor-suppressor gene TP53 and deleted in pancreatic cancer 4 (DPC4) gene defects are seen in those with pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1051496.RAKeFAqTs77gQmfqlnfrhaT20xuKon-YH4oWA3unNw_Z0130_provenance.
• NP1051498.RAJ13jz_sjaKplJ4Vx5PPYeKa7urarWZtXClwOMCqe5Ks130_assertion description "[Genetic mutations, such as activation of the KRAS2 oncogene, inactivation of the tumor-suppressor gene CDKN2A, inactivation of the tumor-suppressor gene TP53 and deleted in pancreatic cancer 4 (DPC4) gene defects are seen in those with pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1051498.RAJ13jz_sjaKplJ4Vx5PPYeKa7urarWZtXClwOMCqe5Ks130_provenance.
• NP1051492.RA2eGBg4QIFmZ1YLsJxxr19QIEvGoYKKWzjEqW29XyxX4130_assertion description "[Genetic mutations, such as activation of the KRAS2 oncogene, inactivation of the tumor-suppressor gene CDKN2A, inactivation of the tumor-suppressor gene TP53 and deleted in pancreatic cancer 4 (DPC4) gene defects are seen in those with pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1051492.RA2eGBg4QIFmZ1YLsJxxr19QIEvGoYKKWzjEqW29XyxX4130_provenance.